Back to Trades
Gengos Andrew
Chief Financial OfficerCIK 0001563623
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Gengos Andrew, Chief Financial Officer, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $8.8M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jul 17 | IMRX Immuneering Corp | Gengos Andrew | Chief Financial Officer | Award | $3.1M |
| Jul 16 | IMRX Immuneering Corp | Gengos Andrew | Chief Financial Officer | Other | $0 |
| Jun 8 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Award | $546.3K |
| Jan 16 | TERN Terns Pharmaceuticals, Inc. | Gengos Andrew | Insider | Grant | $5.1M |
| Oct 10 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Grant | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Other | $0 |
6 filings